Unique ID issued by UMIN | UMIN000033002 |
---|---|
Receipt number | R000037624 |
Scientific Title | Efficacy and safety of reduced port surgery for Colorectal cancer |
Date of disclosure of the study information | 2018/06/15 |
Last modified on | 2020/12/18 12:19:57 |
Efficacy and safety of reduced port surgery for Colorectal cancer
Efficacy and safety of RPS for CRC
Efficacy and safety of reduced port surgery for Colorectal cancer
Efficacy and safety of RPS for CRC
Japan |
Colorectal cancer
Gastrointestinal surgery |
Malignancy
NO
To clarify the safety of reduced port surgery for colorectal cancer
Efficacy
Exploratory
Pragmatic
Phase II
Incidence of adverse event in postoperative 1 month or less
Short-term results (amount of blood loss, operative time, and duration of postoperative hospital stay)
Health related QOL score
Long-term results (5-year over-all survival rate and 5-year relapse-free survival rate)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
NO
Pseudo-randomization
2
Treatment
Maneuver |
Standard procedure with 4-5 access ports in laparoscopic colorectal cancer excision
Reduced-port surgery with 1-2 access ports in laparoscopic colorectal cancer excision
20 | years-old | <= |
Not applicable |
Male and Female
1) Histological proven colorectal carcinoma, clinical stage 0-III
2) Radical cure resection with D2-D3 lymph node dissection is scheduled.
3) Tumor location; Cecum, Ascending colon, Transverse colon, Descending colon, Sigmoid colon and Rectosigmoid colon
4) Tumor diameter is 5.0cm or smaller
5) 20 years old or more
6) Performance Status (ECOG); 0-1
7) No severe dysfunction of internal organs (Fill everything the following with the inspection within 14 days before registration)
White blood cell count > 2,000/mm3 and < 20,000/ mm3
Platelet number > 50,000/ mm3
Haemoglobin > 8.0 g/dl
AST(GOT) ALT(GPT) < 5 times of facilities standard value upper bound
Serum total bilirubin < 3.0 mg/dl
Serum creatinine < 3.0 mg/dl
8) Patient who is obtaining agreement by explanation document
1) Severe hypersensitivity
2) Synchronous or metachronous (within 5 years) malignancy other han carcinoma in situ
3) Active infectious disease
4) Severe mental disease
5) Pregnant or lactating women
6) Severe dysfunction of internal organs
7) History of the organ transplantation
8) Preoperative therapy (chemotherapy, radiotherapy and and hormonal therapy, etc.)
9) Improper patient for clinical trial
90
1st name | Shoichi |
Middle name | |
Last name | Fujii |
Koga Community Hospital
Surgery
425-0088
2-30-1 Daikakuji, Yaizu city, Shizuoka, Japan
054-628-5500
s_fujii631011@yahoo.co.jp
1st name | Manabu |
Middle name | |
Last name | Watanabe |
Koga Community Hospital
Division of medical technology
425-0088
2-30-1 Daikakuji, Yaizu city, Shizuoka, Japan
054-628-5500
http://www.sunkohkai.or.jp/
ku7fk7se@i.softbank.jp
Koga Community Hospital
Department of Surgery
Koga Community Hospital
Division of general affairs
Other
Japan
Teikyo University, Department of Surgery
International University of Health and Welfare, Ichikawa hospital, Department of Gastroenterological surgery
None
Koga Community Hospital, Ethics committee
2-30-1 Daikakuji, Yaizu city, Shizuoka, Japan
054-628-5500
ku7fk7se@i.softbank.jp
YES
Teirin14-021
Teikyo University, Ethics committee
33
International University of Health and Welfare, Ichikawa hospital, Ethics committee
コミュニティーホスピタル駿甲会甲賀病院(静岡県)、国際医療福祉大学市川病院(千葉県)、帝京大学医学部附属病院(東京都)
2018 | Year | 06 | Month | 15 | Day |
http://www.sunkohkai.or.jp/
Unpublished
http://www.sunkohkai.or.jp/
90
No longer recruiting
2014 | Year | 05 | Month | 01 | Day |
2014 | Year | 09 | Month | 03 | Day |
2014 | Year | 09 | Month | 03 | Day |
2025 | Year | 03 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
2025 | Year | 06 | Month | 30 | Day |
2018 | Year | 06 | Month | 15 | Day |
2020 | Year | 12 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037624